Search

Your search keyword '"Marchetti G."' showing total 1,751 results

Search Constraints

Start Over You searched for: Author "Marchetti G." Remove constraint Author: "Marchetti G."
1,751 results on '"Marchetti G."'

Search Results

1. Ospemifene for Genitourinary Syndrome of Menopause: Patient Selection

4. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

5. Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort

7. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort

8. Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort

9. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

10. Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024

11. Advancing river monitoring using image-based techniques: challenges and opportunities

12. HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial

18. STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial

23. OC-0763 SAbR in LA-NSCLC patients unfit for concurrent ChT-RT: START-NEW-ERA non-randomised phase II trial

24. Pillars of long-term antiretroviral therapy success

25. Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study

26. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

27. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

28. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents

30. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

31. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort

32. Five-hub General Conceptual Framework to improve the vaccination coverage for newly arrived migrants

35. Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients

36. Impact of HCV eradication on lipid metabolism in HIV/HCV coinfected patients: Data from ICONA and hepaICONA foundation cohort study

37. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

38. Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss

40. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients

41. Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial

45. A-01 Changes in Fixational Eye Movements (FEMs) Following Concussion

46. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

47. Rehabilitation improves mitochondrial energetics in progressive multiple sclerosis: The significant role of robot-assisted gait training and of the personalized intensity

48. Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis

49. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

50. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

Catalog

Books, media, physical & digital resources